These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

823 related articles for article (PubMed ID: 12015390)

  • 1. High bone density due to a mutation in LDL-receptor-related protein 5.
    Boyden LM; Mao J; Belsky J; Mitzner L; Farhi A; Mitnick MA; Wu D; Insogna K; Lifton RP
    N Engl J Med; 2002 May; 346(20):1513-21. PubMed ID: 12015390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oropharyngeal skeletal disease accompanying high bone mass and novel LRP5 mutation.
    Rickels MR; Zhang X; Mumm S; Whyte MP
    J Bone Miner Res; 2005 May; 20(5):878-85. PubMed ID: 15824861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel LRP5 missense mutation in a patient with a high bone mass phenotype results in decreased DKK1-mediated inhibition of Wnt signaling.
    Balemans W; Devogelaer JP; Cleiren E; Piters E; Caussin E; Van Hul W
    J Bone Miner Res; 2007 May; 22(5):708-16. PubMed ID: 17295608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LRP5 mutations in osteoporosis-pseudoglioma syndrome and high-bone-mass disorders.
    Levasseur R; Lacombe D; de Vernejoul MC
    Joint Bone Spine; 2005 May; 72(3):207-14. PubMed ID: 15850991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of bone formation and vision by LRP5.
    Patel MS; Karsenty G
    N Engl J Med; 2002 May; 346(20):1572-4. PubMed ID: 12015398
    [No Abstract]   [Full Text] [Related]  

  • 6. LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development.
    Gong Y; Slee RB; Fukai N; Rawadi G; Roman-Roman S; Reginato AM; Wang H; Cundy T; Glorieux FH; Lev D; Zacharin M; Oexle K; Marcelino J; Suwairi W; Heeger S; Sabatakos G; Apte S; Adkins WN; Allgrove J; Arslan-Kirchner M; Batch JA; Beighton P; Black GC; Boles RG; Boon LM; Borrone C; Brunner HG; Carle GF; Dallapiccola B; De Paepe A; Floege B; Halfhide ML; Hall B; Hennekam RC; Hirose T; Jans A; Jüppner H; Kim CA; Keppler-Noreuil K; Kohlschuetter A; LaCombe D; Lambert M; Lemyre E; Letteboer T; Peltonen L; Ramesar RS; Romanengo M; Somer H; Steichen-Gersdorf E; Steinmann B; Sullivan B; Superti-Furga A; Swoboda W; van den Boogaard MJ; Van Hul W; Vikkula M; Votruba M; Zabel B; Garcia T; Baron R; Olsen BR; Warman ML;
    Cell; 2001 Nov; 107(4):513-23. PubMed ID: 11719191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum levels of sclerostin, Dickkopf-1, and secreted frizzled-related protein-4 are not changed in individuals with high bone mass causing mutations in LRP5.
    Simpson CA; Foer D; Lee GS; Bihuniak J; Sun B; Sullivan R; Belsky J; Insogna KL
    Osteoporos Int; 2014 Oct; 25(10):2383-8. PubMed ID: 24927689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop.
    Rawadi G; Vayssière B; Dunn F; Baron R; Roman-Roman S
    J Bone Miner Res; 2003 Oct; 18(10):1842-53. PubMed ID: 14584895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New explanation for autosomal dominant high bone mass: Mutation of low-density lipoprotein receptor-related protein 6.
    Whyte MP; McAlister WH; Zhang F; Bijanki VN; Nenninger A; Gottesman GS; Lin EL; Huskey M; Duan S; Dahir K; Mumm S
    Bone; 2019 Oct; 127():228-243. PubMed ID: 31085352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wnt signalling: antagonistic Dickkopfs.
    Zorn AM
    Curr Biol; 2001 Aug; 11(15):R592-5. PubMed ID: 11516963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-bone-mass disease and LRP5.
    Whyte MP; Reinus WH; Mumm S
    N Engl J Med; 2004 May; 350(20):2096-9; author reply 2096-9. PubMed ID: 15141052
    [No Abstract]   [Full Text] [Related]  

  • 12. Pathogenic mutations and polymorphisms in the lipoprotein receptor-related protein 5 reveal a new biological pathway for the control of bone mass.
    Ferrari SL; Deutsch S; Antonarakis SE
    Curr Opin Lipidol; 2005 Apr; 16(2):207-14. PubMed ID: 15767861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-based mutation analysis shows the importance of LRP5 beta-propeller 1 in modulating Dkk1-mediated inhibition of Wnt signaling.
    Bhat BM; Allen KM; Liu W; Graham J; Morales A; Anisowicz A; Lam HS; McCauley C; Coleburn V; Cain M; Fortier E; Bhat RA; Bex FJ; Yaworsky PJ
    Gene; 2007 Apr; 391(1-2):103-12. PubMed ID: 17276019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor.
    Kato M; Patel MS; Levasseur R; Lobov I; Chang BH; Glass DA; Hartmann C; Li L; Hwang TH; Brayton CF; Lang RA; Karsenty G; Chan L
    J Cell Biol; 2002 Apr; 157(2):303-14. PubMed ID: 11956231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localization of the gene causing autosomal dominant osteopetrosis type I to chromosome 11q12-13.
    Van Hul E; Gram J; Bollerslev J; Van Wesenbeeck L; Mathysen D; Andersen PE; Vanhoenacker F; Van Hul W
    J Bone Miner Res; 2002 Jun; 17(6):1111-7. PubMed ID: 12054167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The high bone mass family--the role of Wnt/Lrp5 signaling in the regulation of bone mass.
    Johnson ML
    J Musculoskelet Neuronal Interact; 2004 Jun; 4(2):135-8. PubMed ID: 15615112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dickkopf 3 inhibits invasion and motility of Saos-2 osteosarcoma cells by modulating the Wnt-beta-catenin pathway.
    Hoang BH; Kubo T; Healey JH; Yang R; Nathan SS; Kolb EA; Mazza B; Meyers PA; Gorlick R
    Cancer Res; 2004 Apr; 64(8):2734-9. PubMed ID: 15087387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling.
    Li X; Zhang Y; Kang H; Liu W; Liu P; Zhang J; Harris SE; Wu D
    J Biol Chem; 2005 May; 280(20):19883-7. PubMed ID: 15778503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of the Wnt signaling pathway in osteoblast commitment and differentiation.
    Yavropoulou MP; Yovos JG
    Hormones (Athens); 2007; 6(4):279-94. PubMed ID: 18055419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cloning and expression of Xenopus Lrp5 and Lrp6 genes.
    Houston DW; Wylie C
    Mech Dev; 2002 Sep; 117(1-2):337-42. PubMed ID: 12204281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.